- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Eton Pharmaceuticals Inc (ETON)
Assess today's live Eton Pharmaceuticals Inc (ETON) share price, performance and insights using our live NASDAQ: ETON stock exchange data.
Analyse the historical data and Eton Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Eton Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Eton Pharmaceuticals (ETON) stock price today with other investors in the Eton Pharmaceuticals NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ETON share price (ISIN: US29772L1089) to enhance your trading decisions with our free investment tools and resources.
What Is the Eton Pharmaceuticals Inc Share Price Today?
The Eton Pharmaceuticals share price today is 28.900.
What Is the Stock Symbol for Eton Pharmaceuticals Inc
The stock symbol (or 'ticker') for Eton Pharmaceuticals Inc is "ETON."
What Stock Exchange Does Eton Pharmaceuticals Inc Trade On?
Eton Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Eton Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Eton Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Eton Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Eton Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Eton Pharmaceuticals (ETON) stock price today with other investors in the Eton Pharmaceuticals NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ETON share price (ISIN: US29772L1089) to enhance your trading decisions with our free investment tools and resources.
What Is the Eton Pharmaceuticals Inc Share Price Today?
The Eton Pharmaceuticals share price today is 28.900.
What Is the Stock Symbol for Eton Pharmaceuticals Inc
The stock symbol (or 'ticker') for Eton Pharmaceuticals Inc is "ETON."
What Stock Exchange Does Eton Pharmaceuticals Inc Trade On?
Eton Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Eton Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Eton Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.615
29.800
52 wk Range
13.085
29.800
Unusual trading volume
1/4
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.61529.800
52 wk Range
13.08529.800
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ETON Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
39.333
Upside
+36.10%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 39.333
(+36.10% Upside)
Eton Pharmaceuticals Inc Earnings Call Summary for Q4/2025
- Eton Pharmaceuticals Q4 2025 EPS of $0.19 beat estimates by 5.56%; revenue of $21.3M missed forecasts by 3.01%, stock surged 9.2% to $19.02.
- Revenue jumped 83% year-over-year driven by successful product launches and acquisitions; adjusted EBITDA margin improved to 29% from 18%.
- Company swung to GAAP net income of $1.5M from $0.6M loss in Q4 2024, demonstrating strong profitability turnaround.
- Management expects continued EPS and revenue growth through new product launches and strategic acquisitions to enhance market penetration.
- Key risks include supply chain disruptions, rising R&D/G&A expenses, market saturation, and regulatory approval challenges.
Last Updated: 19/03/2026, 21:50
Read Full TranscriptEarnings
Latest Release
19/03/2026
EPS / Forecast
0.19 / 0.18
Revenue / Forecast
21.3M / 21.96M
Compare ETON to Peers and Sector
Metrics to compare | ETON | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipETONPeersSector | |
|---|---|---|---|---|
P/E Ratio | −171.9x | −6.1x | −0.5x | |
PEG Ratio | 10.83 | 0.11 | 0.00 | |
Price/Book | 30.2x | 1.2x | 2.6x | |
Price / LTM Sales | 9.9x | 1.7x | 3.2x | |
Upside (Analyst Target) | 21.1% | 111.6% | 47.8% | |
Fair Value Upside | Unlock | 10.0% | 6.7% | Unlock |
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Eton Pharmaceuticals (NASDAQ: ETON) Share Price Today?
The Eton Pharmaceuticals stock price today is 28.900 USD.
What Stock Exchange Does Eton Pharmaceuticals (ETON) Trade On?
Eton Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Eton Pharmaceuticals?
The stock symbol (also called a 'ticker') for Eton Pharmaceuticals is "ETON."
What Is the Current Eton Pharmaceuticals Market Capitalisation?
As of today, Eton Pharmaceuticals (NASDAQ: ETON) market cap is 790.700M USD.
What Is Eton Pharmaceuticals's (ETON) Earnings Per Share (TTM)?
The Eton Pharmaceuticals EPS is currently -0.171 (Trailing Twelve Months).
When Is the Next Eton Pharmaceuticals Earnings Date?
Eton Pharmaceuticals's next earnings report will be released on 07/05/2026.
Is ETON a Buy or Sell From a Technical Analyst Perspective?
Based on today's Eton Pharmaceuticals moving averages and other technical indicators, the daily buy/sell signal for ETON stock is Strong Buy.
How Many Times Has Eton Pharmaceuticals Stock Split?
Eton Pharmaceuticals has split 0 times. (See the ETON stock split history page for full effective split date and price information.)
How Many Employees Does Eton Pharmaceuticals Have?
Eton Pharmaceuticals has 44 employees, based on their latest Companies House report.
What is the current trading status of Eton Pharmaceuticals (NASDAQ: ETON)?
As of 02/05/2026, Eton Pharmaceuticals (ETON) is trading at a share price of 28.900 USD, with a previous close of 24.120 USD. The stock has fluctuated within a day range of 24.615 USD to 29.800 USD, while its 52-week range spans from 13.085 USD to 29.800 USD.
What Is Eton Pharmaceuticals (ETON) Price Target According to Analysts?
The average 12-month price target for Eton Pharmaceuticals is 39.333 USD, with a high estimate of 52 USD and a low estimate of 31 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +36.10% Upside potential.
What Is the ETON After Hours Price?
ETON's last after hours stock price is 29.100 USD, the stock has decreased by 0.200, or 0.690%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.